Paper35636746
Projected Impact of Expanded Long-Acting Injectable PrEP Use Among Men Who Have Sex With Men on Local HIV Epidemics.
Balasubramanian R and 5 others. J Acquir Immune Defic Syndr, 2022. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Projected Impact of Expanded Long-Acting Injectable PrEP Use Among Men Who Have Sex With Men on Local HIV Epidemics. Papers, record 35636746. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35636746
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Projected Impact of Expanded Long-Acting Injectable PrEP Use Among Men Who Have Sex With Men on Local HIV Epidemics.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-HIV Agents | Major topic |
| Epidemics | Major topic |
| HIV Infections | Major topic |
| Pre-Exposure Prophylaxis | Major topic |
| Sexual and Gender Minorities | Major topic |
| Homosexuality, Male | |
| Humans | |
| Male | |
| United States |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 AI094189 | NIAID NIH HHS | United States | P30AI094189 | PubMed and NIH | NIH RePORTER |
| K08 MH118094 | NIMH NIH HHS | United States | K08MH118094 | PubMed and NIH | NIH RePORTER |
| T32 HL007024 | NHLBI NIH HHS | United States | T32HL007024 | PubMed and NIH | NIH RePORTER |
| R01 MD018539 | NIMHD NIH HHS | United States | R01MD018539 | PubMed | NIH RePORTER |
| T32 AI102623 | NIAID NIH HHS | United States | T32AI102623 | PubMed and NIH | NIH RePORTER |
| K01 AI138853 | NIAID NIH HHS | United States | K01AI138853 | PubMed and NIH | NIH RePORTER |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42818812 | Avoiding the cost of complacency: barriers and solutions to ending the HIV epidemic in Europe. | Front Public Health | 2026 | https://conductscience.org/library/papers/42818812 | PubMed |
| 42672112 | Prospects of HIV elimination among men who have sex with men: A systematic review of modeling studies. | PLoS Comput Biol | 2026 | https://conductscience.org/library/papers/42672112 | PubMed |
| 42573428 | Modelling the 5-Year Impact of Twice-Yearly Injectable Lenacapavir for HIV Pre-Exposure Prophylaxis in the United States. | J Int AIDS Soc | 2026 | https://conductscience.org/library/papers/42573428 | PubMed |
| 42178143 | Equity and Access in HIV Prevention: Addressing Global Disparities in PrEP Use Among Men Who Have Sex With Men Population. | Am J Mens Health | 2026 | https://conductscience.org/library/papers/42178143 | PubMed |
| 40755213 | The great mismatch: unfulfilled promise of biomedical HIV prevention. | AIDS | 2025 | https://conductscience.org/library/papers/40755213 | PubMed |
| 39934566 | Early Implementation of Long-Acting Injectable Cabotegravir for HIV Prevention in a Safety Net Hospital-based Primary Care Center in U.S. South. | J Gen Intern Med | 2026 | https://conductscience.org/library/papers/39934566 | PubMed |
| 39484783 | High Retention and Adherence With Rapid Long-acting Injectable Preexposure Prophylaxis Implementation in an Urban Safety Net Clinic Population. | Clin Infect Dis | 2025 | https://conductscience.org/library/papers/39484783 | PubMed |
| 38838028 | Phase 1 randomized trials to assess safety, pharmacokinetics, and vaginal bleeding associated with use of extended duration dapivirine and levonorgestrel vaginal rings. | PLoS One | 2024 | https://conductscience.org/library/papers/38838028 | PubMed |
| 38791816 | LAI-ART Awareness, Willingness, Barriers and Facilitators among Black Sexual Minority Men Living with HIV in the US South. | Int J Environ Res Public Health | 2024 | https://conductscience.org/library/papers/38791816 | PubMed |
| 38720248 | Need for informed providers: exploring LA-PrEP access in focus groups with PrEP-indicated communities in Baltimore, Maryland. | BMC Public Health | 2024 | https://conductscience.org/library/papers/38720248 | PubMed |
| 37606684 | New USPSTF Guidelines for HIV Preexposure Prophylaxis: Will More Choices Lead to Greater Impact? | JAMA | 2023 | https://conductscience.org/library/papers/37606684 | PubMed |
| 36006246 | Long-Acting Injectable Drugs for HIV-1 Pre-Exposure Prophylaxis: Considerations for Africa. | Trop Med Infect Dis | 2022 | https://conductscience.org/library/papers/36006246 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35636746
GET https://conductscience.org/api/papers/v1/35636746/authors